Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 11, 2015 - Issue 3
Submit an article Journal homepage
1,794
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine

Vladimir GilcaQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, CanadaCorrespondence[email protected]
,
Chantal SauvageauQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, Canada
,
Nicole BoulianneQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, Canada
,
Gatson De SerresQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, Canada
,
Mel CrajdenBC Center for Disease Control; Public Health Microbiology and Reference Laboratory; Vancouver, British Columbia, Canada
,
Manale OuakkiQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, Canada
,
Andrea TrevisanQuebec Public Health Institute; Laval University; Quebec University Research Hospital Center; Quebec, Canada
&
Marc Dionne
 show all
Pages 732-738 | Received 26 Sep 2014, Accepted 21 Nov 2014, Published online: 03 Apr 2015

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zheng Quan Toh, Jennie Kosasih, Fiona M Russell, Suzanne M Garland, Edward K Mulholland & Paul V Licciardi. (2019) Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infection and Drug Resistance 12, pages 1951-1967.
Read now
J. Patricia Dhar, Lynnette Essenmacher, Renee Dhar, Ardella Magee, Joel Ager & Robert J. Sokol. (2018) The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus. Human Vaccines & Immunotherapeutics 14:9, pages 2318-2322.
Read now

Articles from other publishers (15)

Patricia Piña-Sánchez. (2022) Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer. Archives of Medical Research 53:8, pages 753-769.
Crossref
Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Maria Vardaka, Anthi Mpouhla, Eleni Variami, Athanasios Galanopoulos, Vassiliki Pappa, Mina Psichogiou, Angelos Hatzakis & Nora-Athina Viniou. (2022) Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection. Annals of Hematology 101:12, pages 2711-2717.
Crossref
Andrea Trevisan, Michel D. Wissing, Carole Dagenais, Pierre Forest, Agnihotram V. Ramanakumar, Ann N. Burchell, Eduardo L. Franco, François Coutlée & Michel Couillard. (2021) Development and evaluation of a new non-competitive Luminex immunoassay detecting antibodies against human papillomavirus types 6, 11, 16 and 18. Journal of General Virology 102:5.
Crossref
Ramadhani Salum Chambuso, George Rebello & Evelyn Kaambo. (2020) Personalized Human Papillomavirus Vaccination for Persistence of Immunity for Cervical Cancer Prevention: A Critical Review With Experts' Opinions. Frontiers in Oncology 10.
Crossref
Elisabeth McClymont, Gina Ogilvie, Arianne Albert, Angela Johnston, Janet Raboud, Sharon Walmsley, Nancy Lipsky, Mona Loutfy, Sylvie Trottier, Fiona Smaill, Mark H. Yudin, Marina B. Klein, Marianne Harris, Wendy Wobeser, Ari Bitnun, Fatima Kakkar, Lindy Samson, Jason Brophy, Christos Karatzios & Deborah Money. (2020) Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV. Vaccine 38:15, pages 3073-3078.
Crossref
Hanna Bergman, Brian S Buckley, Gemma Villanueva, Jennifer Petkovic, Chantelle Garritty, Vittoria Lutje, Alina Ximena Riveros-Balta, Nicola Low & Nicholas Henschke. (2019) Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database of Systematic Reviews 2019:11.
Crossref
Vladimir Gilca, Chantal Sauvageau & Gaston De Serres. (2019) A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine. Vaccine 37:32, pages 4422-4423.
Crossref
Eduardo Lazcano-Ponce, Leticia Torres-Ibarra, Aurelio Cruz-Valdez, Jorge Salmerón, Tonatiuh Barrientos-Gutiérrez, Javier Prado-Galbarro, Margaret Stanley, Nubia Muñoz, Rolando Herrero & Mauricio Hernández-Ávila. (2019) Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination. The Journal of Infectious Diseases 219:1, pages 41-49.
Crossref
Claudia Robles, María de la Luz Hernández & Maribel Almonte. (2018) Alternative HPV vaccination schedules in Latin America. Salud Pública de México 60:6, nov-dic, pages 693.
Crossref
Margaret Stanley. (2018) Realities of alternative HPV vaccination schedules. Salud Pública de México 60:6, nov-dic, pages 617.
Crossref
Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, Manale Ouakki & Elizabeth R. Unger. (2018) Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine – A randomized clinical trial. Vaccine 36:46, pages 7017-7024.
Crossref
Anastasia Phillips, Cyra Patel, Alexis Pillsbury, Julia Brotherton & Kristine Macartney. (2017) Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety 41:4, pages 329-346.
Crossref
Diane M. Harper & Leslie R. DeMars. (2017) HPV vaccines – A review of the first decade. Gynecologic Oncology 146:1, pages 196-204.
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 307 334 .
Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle & Roberto Gasparini. 2015. 231 322 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.